Published in J Biol Chem on November 25, 1985
tRNA(Trp) translation of leader peptide codon 12 and other factors that regulate expression of the tryptophanase operon. J Bacteriol (1990) 1.48
Evidence suggesting cis action by the TnaC leader peptide in regulating transcription attenuation in the tryptophanase operon of Escherichia coli. J Bacteriol (1995) 1.06
Synthetic Studies of 3-(3-Fluorooxindol-3-yl)-l-alanine. J Fluor Chem (2008) 0.75
Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA (1998) 12.60
Effect of computer-based alerts on the treatment and outcomes of hospitalized patients. Arch Intern Med (1994) 8.20
Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1997) 6.55
Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabilization of tumor necrosis factor alpha mRNA. Mol Cell Biol (1999) 5.55
Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med (1997) 4.56
Modification of histidyl residues in proteins by diethylpyrocarbonate. Methods Enzymol (1977) 4.25
Do formal advance directives affect resuscitation decisions and the use of resources for seriously ill patients? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Clin Ethics (1994) 4.23
Three-dimensional structure of the tryptophan synthase alpha 2 beta 2 multienzyme complex from Salmonella typhimurium. J Biol Chem (1988) 3.52
Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med (2000) 3.49
Health values of hospitalized patients 80 years or older. HELP Investigators. Hospitalized Elderly Longitudinal Project. JAMA (1998) 3.47
Do advance directives provide instructions that direct care? SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc (1997) 3.37
Use of administrative data to find substandard care: validation of the complications screening program. Med Care (2000) 3.26
Resuscitation preferences among patients with severe congestive heart failure: results from the SUPPORT project. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Circulation (1998) 3.11
The SUPPORT prognostic model. Objective estimates of survival for seriously ill hospitalized adults. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med (1995) 3.08
Development of the 'Activities of Daily Vision Scale'. A measure of visual functional status. Med Care (1992) 3.06
Patterns of use, expenditures, and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med (1998) 2.85
Physician counseling about exercise. JAMA (1999) 2.85
Advance directives for seriously ill hospitalized patients: effectiveness with the patient self-determination act and the SUPPORT intervention. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc (1997) 2.84
A comparative study of contrast agents for endoscopic retrograde pancreatography. Am J Gastroenterol (1991) 2.75
Does clinical evidence support ICD-9-CM diagnosis coding of complications? Med Care (2000) 2.74
Use of a direct fluorescent antibody test for detecting Chlamydia trachomatis cervical infection in women seeking routine gynecologic care. J Infect Dis (1987) 2.40
The role of TH1 and TH2 cells in a rodent malaria infection. Science (1993) 2.38
Older age, aggressiveness of care, and survival for seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1999) 2.34
Alternative medicine use in older Americans. J Am Geriatr Soc (2000) 2.32
The effect of computer-based reminders on the management of hospitalized patients with worsening renal function. Proc Annu Symp Comput Appl Med Care (1991) 2.22
Health values of the seriously ill. SUPPORT investigators. Ann Intern Med (1995) 2.14
Rate acceleration by stereopopulation control: models for enzyme action. Proc Natl Acad Sci U S A (1970) 2.13
Pressure dissociation and conformational drift of the beta dimer of tryptophan synthase. Biochemistry (1986) 2.12
Communication and decision-making in seriously ill patients: findings of the SUPPORT project. The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.12
Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc (2000) 2.09
Patients discharged against medical advice from a general medicine service. J Gen Intern Med (1998) 2.04
Patient-physician communication at hospital discharge and patients' understanding of the postdischarge treatment plan. Arch Intern Med (1997) 2.00
Indole can act as an extracellular signal to regulate biofilm formation of Escherichia coli and other indole-producing bacteria. Can J Microbiol (2003) 1.98
Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch Ophthalmol (1994) 1.93
Relationship of body mass index to subsequent mortality among seriously ill hospitalized patients. SUPPORT Investigators. The Study to Understand Prognoses and Preferences for Outcome and Risks of Treatments. Crit Care Med (1997) 1.89
Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur J Immunol (1994) 1.89
Immunity to malaria. II. Serological response of monkeys sensitized by drug-suppressed infection or by dead parasitized cells in Freund's complete adjuvant. Exp Parasitol (1970) 1.86
The last six months of life for patients with congestive heart failure. J Am Geriatr Soc (2000) 1.82
Patient age and decisions to withhold life-sustaining treatments from seriously ill, hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med (1999) 1.81
Method to test inhibitory antibodies in human sera to wild populations of Plasmodium falciparum. Nature (1976) 1.79
Does the Complications Screening Program flag cases with process of care problems? Using explicit criteria to judge processes. Int J Qual Health Care (1999) 1.71
Surrogates' predictions of seriously ill patients' resuscitation preferences. Arch Fam Med (1995) 1.70
Factors associated with do-not-resuscitate orders: patients' preferences, prognoses, and physicians' judgments. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Ann Intern Med (1996) 1.69
Should tests for Chlamydia trachomatis cervical infection be done during routine gynecologic visits? An analysis of the costs of alternative strategies. Ann Intern Med (1987) 1.65
Effect of physician gender on the prescription of estrogen replacement therapy. J Gen Intern Med (1996) 1.63
Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med (2000) 1.62
Influence of financial productivity incentives on the use of preventive care. Am J Med (2001) 1.61
Comparison of the quality of ambulatory care for fee-for-service and prepaid patients. Ann Intern Med (1991) 1.59
Dying with cancer: patients' function, symptoms, and care preferences as death approaches. J Am Geriatr Soc (2000) 1.58
Forceful balloon dilation: an outpatient procedure for achalasia. Gastrointest Endosc (1990) 1.58
Factors associated with change in resuscitation preference of seriously ill patients. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Arch Intern Med (1996) 1.56
Standard biopsy forceps versus large-capacity forceps with and without needle. Gastrointest Endosc (1995) 1.53
Plasmodium berghei: passive transfer of immunity by antisera and cells. Exp Parasitol (1970) 1.52
Plasmodium chabaudi: antigenic variation during recrudescent parasitaemias in mice. Exp Parasitol (1982) 1.52
Health status versus quality of life in older patients: does the distinction matter? Am J Med (1999) 1.50
Relationship between smoking and weight control efforts among adults in the united states. Arch Intern Med (2001) 1.48
Rethinking fundamental assumptions: SUPPORT's implications for future reform. Study to Understand Prognoses and Preferences and Risks of Treatment. J Am Geriatr Soc (2000) 1.47
Factors associated with use of cardiopulmonary resuscitation in seriously ill hospitalized adults. JAMA (1999) 1.46
Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Ann Intern Med (1998) 1.45
Physician understanding of patient resuscitation preferences: insights and clinical implications. J Am Geriatr Soc (2000) 1.44
Breast cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst (1997) 1.42
Family satisfaction with end-of-life care in seriously ill hospitalized adults. J Am Geriatr Soc (2000) 1.42
The illusion of end-of-life resource savings with advance directives. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. J Am Geriatr Soc (1997) 1.42
Malaria parasites undergo antigenic variation at high rates in vivo. Proc Biol Sci (1994) 1.41
Tryptophan synthase: structure, function, and subunit interaction. Adv Enzymol Relat Areas Mol Biol (1979) 1.41
Correlating nutrition to recent cancer mortality statistics. J Natl Cancer Inst (1997) 1.39
Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Ann Intern Med (1997) 1.39
Chlamydial cervical infection in jailed women. Am J Public Health (1993) 1.36
Patients who want their family and physician to make resuscitation decisions for them: observations from SUPPORT and HELP. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Hospitalized Elderly Longitudinal Project. J Am Geriatr Soc (2000) 1.36
Age-related differences in care preferences, treatment decisions, and clinical outcomes of seriously ill hospitalized adults: lessons from SUPPORT. J Am Geriatr Soc (2000) 1.34
Spontaneous cholecystocolonic fistula treated by endoscopic sphincterotomy. Gastrointest Endosc (1988) 1.31
Nutrition and its relationship to cancer. Adv Cancer Res (1980) 1.29
Domain architecture of the heme-independent yeast cystathionine beta-synthase provides insights into mechanisms of catalysis and regulation. Biochemistry (2000) 1.27
Predicting in-hospital mortality. The importance of functional status information. Med Care (1995) 1.26
Preferences for cardiopulmonary resuscitation: physician-patient agreement and hospital resource use. The SUPPORT Investigators. J Gen Intern Med (1995) 1.26
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Prediction of survival for older hospitalized patients: the HELP survival model. Hospitalized Elderly Longitudinal Project. J Am Geriatr Soc (2000) 1.24
Three-dimensional structure of tyrosine phenol-lyase. Biochemistry (1993) 1.24
Immunity to Plasmodium berghei in rats: maximum levels of protective antibody activity are associated with eradication of the infection. Parasitology (1972) 1.22
Gene discovery in Plasmodium chabaudi by genome survey sequencing. Mol Biochem Parasitol (2001) 1.22
B cells are required for the switch from Th1- to Th2-regulated immune responses to Plasmodium chabaudi chabaudi infection. Infect Immun (1994) 1.21
Proteolytic modification of the amino-terminal and carboxyl-terminal regions of rat hepatic phenylalanine hydroxylase. J Biol Chem (1986) 1.19
Yeast cystathionine beta-synthase is a pyridoxal phosphate enzyme but, unlike the human enzyme, is not a heme protein. J Biol Chem (2000) 1.17
Culture of Plasmodium falciparum in vitro: a subculture technique used for demonstrating antiplasmodial activity in serum from some Gambians, resident in an endemic malarious area. Parasitology (1972) 1.16
Tryptophan synthase from Escherichia coli and Salmonella typhimurium. Methods Enzymol (1987) 1.13
Group-specific reagents in protein chemistry. Annu Rev Biochem (1968) 1.13
Dietary fat and mammary cancer. I. Promoting effects of different dietary fats on N-nitrosomethylurea-induced rat mammary tumorigenesis. J Natl Cancer Inst (1986) 1.13
The conservation of oxidative energy in phosphate-free systems. Formation of acyl anhydrides via the oxidation of hydroquinone monocarboxylic esters. Biochim Biophys Acta (1969) 1.13
Microangiography in bone healing. II. Displaced closed fractures. J Bone Joint Surg Am (1968) 1.12
Intention to discontinue care among primary care patients: influence of physician behavior and process of care. J Gen Intern Med (2001) 1.11
Stereopopulation control. I. Rate enhancement in the lactonizations of 0-hydroxyhydrocinnamic acids. J Am Chem Soc (1972) 1.11
Predicting functional status outcomes in hospitalized patients aged 80 years and older. J Am Geriatr Soc (2000) 1.10
Functional characterization of protective CD4+ T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology (1992) 1.07
Prior capacity of patients lacking decision making ability early in hospitalization: implications for advance directive administration. The SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Gen Intern Med (1994) 1.07
Spectroscopic investigation of ligand interaction with hepatic phenylalanine hydroxylase: evidence for a conformational change associated with activation. Biochemistry (1984) 1.06